Quest Laborato. — 360° view

Quest Laborato, a company in the Pharmaceuticals industry, reported revenue of ₹55 crore and net profit of ₹9.00 crore for the September 2026 quarter.

Quest Laborato. (NSE: QUESTLAB-SM) closed at ₹92.00 on 20 Nov 2026, up 3.4% over the past year. Its market capitalisation is ₹151 crore and it trades at 9.5 times earnings.

Share price
₹92.00 (20 Nov 2026)
Market cap
₹151 Cr (20 Nov 2026)
P/E
9.47 (20 Nov 2026)
Revenue
₹55 Cr (September 2026 quarter)
Net profit
₹9 Cr (September 2026 quarter)
ROCE
18.3% (FY26)
ROE
16.6% (FY26)
Book value
₹64.6 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹152.60 / ₹68.60 (20 Nov 2026)
1-year return
3.4% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: QUESTLAB-SM

Incorporated in 1998, Quest Laboratories Ltd is a pharmaceutical manufacturer specializing in diverse therapeutic segments

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.